BeiGene (ONC) Cash From Financing

Annual CFF

$416.48 M
+$435.45 M+2295.34%

December 1, 2023

Summary

Performance

1-Year Change

+2295.34%

3-Year Change

-92%

5-Year Change

-75.36%

15-Year Change

-15.07%

ONC Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.23%
ONC annual cash flow from financing activities is higher than 97.23% of companies in Healthcare sector

High & Low

All-time High

$5.20 B
ONC annual cash flow from financing activities is currently -92.00% below its historical high of $5.20 billion

3-Year Low

-$18.97 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ONC previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Feb 26, 2025
ONC next annual earnings announcement is scheduled for Feb 26, 2025

OtherONCcash flowmetrics:

Annual CFI

$60.00 M
ONC annual cash flow from investing activities is $60.00 million

Annual CFO

-$1.16 B
ONC annual cash flow from operations is -$1.16 billion

Annual FCF

-$1.75 B
ONC annual free cash flow is -$1.75 billion

Annual CAPEX

$596.26 M
ONC annual capital expenditures is $596.26 million

Quarterly CFF

$12.66 M
-$10.36 M-44.99%

September 1, 2024

Summary

Performance

3-Month Change

-44.99%

1-Year Change

-96.35%

3-Year Change

+111.47%

5-Year Change

+111.47%

ONC Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.3%
ONC quarterly cash flow from financing activities is higher than 87.3% of companies in Healthcare sector

High & Low

All-time High

$3.38 B
ONC quarterly cash flow from financing activities is currently -99.63% below its historical high of $3.38 billion

3-Year Low

-$110.37 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ONC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
ONC next earnings announcement is scheduled for Feb 26, 2025

OtherONCcash flowmetrics:

Quarterly CFI

-$133.88 M
ONC quarterly cash flow from investing activities is -$133.88 million

Quarterly CFO

$188.37 M
ONC quarterly cash flow from operations is $188.37 million

Quarterly FCF

$54.71 M
ONC quarterly free cash flow is $54.71 million

Quarterly CAPEX

$133.66 M
ONC quarterly capital expenditures is $133.66 million

TTM CFF

$545.02 M
+$89.44 M+19.63%

September 1, 2024

Summary

Performance

3-Month Change

+19.63%

1-Year Change

+30.86%

3-Year Change

+2972.91%

5-Year Change

+2972.91%

ONC TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.02%
ONC TTM cash flow from financing activities is higher than 97.02% of companies in Healthcare sector

High & Low

All-time High

$5.20 B
ONC TTM cash flow from financing activities is currently -89.52% below its historical high of $5.20 billion

3-Year Low

-$40.94 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ONC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
ONC next earnings announcement is scheduled for Feb 26, 2025

OtherONCcash flowmetrics:

TTM CFI

-$517.33 M
ONC TTM cash flow from investing activities is -$517.33 million

TTM CFO

-$437.43 M
ONC TTM cash flow from operations is -$437.43 million

TTM FCF

-$1.04 B
ONC TTM free cash flow is -$1.04 billion

TTM CAPEX

$603.57 M
ONC TTM capital expenditures is $603.57 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ONC Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2295.3%-96.3%+30.9%
3 y3 years-92.0%+111.5%+2972.9%
5 y5 years-75.4%+111.5%+2972.9%

ONC Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-88.5%+2295.3%-99.6%+111.5%-85.0%+1431.4%
5 y5-year-92.0%+2295.3%-99.6%+111.5%-89.5%+1431.4%
alltimeall time-92.0%+2295.3%-99.6%+111.5%-89.5%+1431.4%

BeiGene Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$12.66 M(-45.0%)
$545.02 M(+19.6%)
Jun 2024
-
$23.02 M(-85.8%)
$455.58 M(-23.9%)
Mar 2024
-
$162.29 M(-53.2%)
$598.64 M(+43.7%)
Dec 2023
$416.48 M(-2295.3%)
$347.05 M(-552.0%)
$416.48 M(-1117.4%)
Sep 2023
-
-$76.78 M(-146.2%)
-$40.94 M(-126.2%)
Jun 2023
-
$166.08 M(-935.9%)
$156.09 M(-666.1%)
Mar 2023
-
-$19.87 M(-82.0%)
-$27.57 M(+45.3%)
Dec 2022
-$18.97 M(-100.5%)
-$110.37 M(-191.8%)
-$18.97 M(-100.5%)
Sep 2022
-
$120.24 M(-784.0%)
$3.48 B(+0.3%)
Jun 2022
-
-$17.58 M(+56.0%)
$3.47 B(-1.5%)
Mar 2022
-
-$11.27 M(-100.3%)
$3.52 B(-3.3%)
Dec 2021
$3.64 B(-30.1%)
$3.38 B(+2999.3%)
$3.64 B(+529.3%)
Sep 2021
-
$109.21 M(+206.5%)
$577.91 M(-76.5%)
Jun 2021
-
$35.63 M(-66.8%)
$2.46 B(-1.8%)
Mar 2021
-
$107.42 M(-67.0%)
$2.51 B(-51.8%)
Dec 2020
$5.20 B(+5972.4%)
$325.66 M(-83.7%)
$5.20 B(+6.6%)
Sep 2020
-
$1.99 B(+2361.9%)
$4.88 B(+67.6%)
Jun 2020
-
$80.99 M(-97.1%)
$2.91 B(+2.3%)
Mar 2020
-
$2.80 B(>+9900.0%)
$2.84 B(+3220.4%)
Dec 2019
$85.68 M
$2.20 M(-91.3%)
$85.68 M(-7.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
$25.14 M(+63.4%)
$92.28 M(-90.2%)
Jun 2019
-
$15.38 M(-64.2%)
$938.40 M(-3.2%)
Mar 2019
-
$42.96 M(+388.1%)
$969.60 M(-42.6%)
Dec 2018
$1.69 B(+244.8%)
$8.80 M(-99.0%)
$1.69 B(+0.3%)
Sep 2018
-
$871.25 M(+1770.3%)
$1.68 B(+46.1%)
Jun 2018
-
$46.58 M(-93.9%)
$1.15 B(-7.9%)
Mar 2018
-
$763.90 M(>+9900.0%)
$1.25 B(+155.3%)
Dec 2017
$490.36 M(+28.7%)
$3.05 M(-99.1%)
$490.36 M(-28.5%)
Sep 2017
-
$339.71 M(+134.2%)
$686.00 M(+93.8%)
Jun 2017
-
$145.07 M(+5627.1%)
$353.93 M(+65.9%)
Mar 2017
-
$2.53 M(-98.7%)
$213.39 M(-44.0%)
Dec 2016
$380.90 M(+269.1%)
$198.69 M(+2500.7%)
$380.90 M(+109.2%)
Sep 2016
-
$7.64 M(+69.0%)
$182.09 M(+0.7%)
Jun 2016
-
$4.52 M(-97.3%)
$180.82 M(-33.8%)
Mar 2016
-
$170.05 M(<-9900.0%)
$273.25 M(+164.8%)
Dec 2015
$103.20 M(+97.8%)
-$119.00 K(-101.9%)
$103.20 M(-0.1%)
Sep 2015
-
$6.37 M(-93.4%)
$103.32 M(+6.6%)
Jun 2015
-
$96.95 M(>+9900.0%)
$96.95 M(>+9900.0%)
Mar 2015
-
$0.00
$0.00
Dec 2014
$52.16 M(<-9900.0%)
-
-
Dec 2013
-$482.00 K
-
-

FAQ

  • What is BeiGene annual cash flow from financing activities?
  • What is the all time high annual CFF for BeiGene?
  • What is BeiGene annual CFF year-on-year change?
  • What is BeiGene quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for BeiGene?
  • What is BeiGene quarterly CFF year-on-year change?
  • What is BeiGene TTM cash flow from financing activities?
  • What is the all time high TTM CFF for BeiGene?
  • What is BeiGene TTM CFF year-on-year change?

What is BeiGene annual cash flow from financing activities?

The current annual CFF of ONC is $416.48 M

What is the all time high annual CFF for BeiGene?

BeiGene all-time high annual cash flow from financing activities is $5.20 B

What is BeiGene annual CFF year-on-year change?

Over the past year, ONC annual cash flow from financing activities has changed by +$435.45 M (+2295.34%)

What is BeiGene quarterly cash flow from financing activities?

The current quarterly CFF of ONC is $12.66 M

What is the all time high quarterly CFF for BeiGene?

BeiGene all-time high quarterly cash flow from financing activities is $3.38 B

What is BeiGene quarterly CFF year-on-year change?

Over the past year, ONC quarterly cash flow from financing activities has changed by -$334.39 M (-96.35%)

What is BeiGene TTM cash flow from financing activities?

The current TTM CFF of ONC is $545.02 M

What is the all time high TTM CFF for BeiGene?

BeiGene all-time high TTM cash flow from financing activities is $5.20 B

What is BeiGene TTM CFF year-on-year change?

Over the past year, ONC TTM cash flow from financing activities has changed by +$128.54 M (+30.86%)